$BCDA
BioCardia, Inc.

2018 Q3 Form 10-Q Financial Statement

#000143774918019949 Filed on November 08, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3
Revenue $84.00K $130.0K
YoY Change -35.38% 11.11%
Cost Of Revenue $109.0K $147.0K
YoY Change -25.85% -25.0%
Gross Profit -$25.00K -$17.00K
YoY Change 47.06% -78.48%
Gross Profit Margin -29.76% -13.08%
Selling, General & Admin $1.283M $1.322M
YoY Change -2.95% 43.85%
% of Gross Profit
Research & Development $2.262M $1.700M
YoY Change 33.06% 148.54%
% of Gross Profit
Depreciation & Amortization $22.00K $21.00K
YoY Change 4.76% 133.33%
% of Gross Profit
Operating Expenses $3.545M $3.022M
YoY Change 17.31% 88.52%
Operating Profit -$3.570M -$3.039M
YoY Change 17.47% 80.68%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $26.00K $38.00K
YoY Change -31.58% -102.42%
Pretax Income -$3.540M -$3.000M
YoY Change 18.0% -158.59%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.544M -$3.001M
YoY Change 18.09% -7.78%
Net Earnings / Revenue -4219.05% -2308.46%
Basic Earnings Per Share
Diluted Earnings Per Share -$832.9K -$707.5K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.820M $15.13M
YoY Change -68.14% -22.17%
Cash & Equivalents $4.820M $13.33M
Short-Term Investments $1.800M
Other Short-Term Assets $220.0K $190.0K
YoY Change 15.79% 280.0%
Inventory $134.0K $240.0K
Prepaid Expenses $224.0K $188.0K
Receivables $170.0K $90.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $5.348M $15.64M
YoY Change -65.81% -19.7%
LONG-TERM ASSETS
Property, Plant & Equipment $154.0K $163.0K
YoY Change -5.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $54.00K $54.00K
YoY Change 0.0%
Total Long-Term Assets $208.0K $217.0K
YoY Change -4.15%
TOTAL ASSETS
Total Short-Term Assets $5.348M $15.64M
Total Long-Term Assets $208.0K $217.0K
Total Assets $5.556M $15.86M
YoY Change -64.97% -18.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.102M $447.0K
YoY Change 146.53% 35.45%
Accrued Expenses $226.0K $487.0K
YoY Change -53.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.532M $2.000M
YoY Change 26.6% 506.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $80.00K $80.00K
YoY Change 0.0%
Total Long-Term Liabilities $80.00K $80.00K
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.532M $2.000M
Total Long-Term Liabilities $80.00K $80.00K
Total Liabilities $2.612M $2.075M
YoY Change 25.88% 528.79%
SHAREHOLDERS EQUITY
Retained Earnings -$82.72M -$68.96M
YoY Change 19.95%
Common Stock $38.00K $38.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.944M $13.79M
YoY Change
Total Liabilities & Shareholders Equity $5.556M $15.86M
YoY Change -64.97% -18.58%

Cashflow Statement

Concept 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$3.544M -$3.001M
YoY Change 18.09% -7.78%
Depreciation, Depletion And Amortization $22.00K $21.00K
YoY Change 4.76% 133.33%
Cash From Operating Activities -$2.010M -$1.780M
YoY Change 12.92% 56.14%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 -$10.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 10.00K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.010M -1.780M
Cash From Investing Activities 0.000 -10.00K
Cash From Financing Activities 0.000 10.00K
Net Change In Cash -2.010M -1.780M
YoY Change 12.92% 56.14%
FREE CASH FLOW
Cash From Operating Activities -$2.010M -$1.780M
Capital Expenditures $0.00 -$10.00K
Free Cash Flow -$2.010M -$1.770M
YoY Change 13.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
false
CY2018Q3 bcda Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1430000
CY2017Q4 bcda Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1263000
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1102000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
902000
CY2018Q3 bcda Grant Liability Current
GrantLiabilityCurrent
666000
CY2017Q4 bcda Grant Liability Current
GrantLiabilityCurrent
663000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
226000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
129000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
823000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
758000
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
85625000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
83537000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
730000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
701000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2083000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1999000
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5816465
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4240688
CY2018Q3 us-gaap Assets
Assets
5556000
CY2017Q4 us-gaap Assets
Assets
13538000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
5348000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
13315000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4820000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12689000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21352000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13326000
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7869000
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8026000
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38277908
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38218660
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38277908
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38218660
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
38000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
38000
CY2018Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
66000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
57000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
109000
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
147000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
401000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
525000
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
3654000
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
3169000
us-gaap Costs And Expenses
CostsAndExpenses
10964000
us-gaap Costs And Expenses
CostsAndExpenses
9261000
CY2018Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
83000
CY2017Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
61000
CY2018Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
80000
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
81000
CY2018Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
167000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
455000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
410000
CY2018Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2017Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5600000
CY2018Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
62000
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
70000
CY2018Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
200000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-80000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
75000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
141000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
545000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-1000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
19000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-65000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
89000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-57000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
105000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-116000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-168000
CY2018Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
69000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
29000
CY2018Q3 us-gaap Inventory Net
InventoryNet
134000
CY2017Q4 us-gaap Inventory Net
InventoryNet
191000
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
92000
CY2018Q3 us-gaap Inventory Write Down
InventoryWriteDown
13000
CY2017Q3 us-gaap Inventory Write Down
InventoryWriteDown
15000
us-gaap Inventory Write Down
InventoryWriteDown
15000
us-gaap Inventory Write Down
InventoryWriteDown
25000
CY2018Q3 us-gaap Liabilities
Liabilities
2612000
CY2017Q4 us-gaap Liabilities
Liabilities
2413000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5556000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13538000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2532000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2332000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1906000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7823000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6146000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-3544000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-3001000
us-gaap Net Income Loss
NetIncomeLoss
-10345000
us-gaap Net Income Loss
NetIncomeLoss
-8822000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26000
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
38000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
97000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
60000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3570000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3039000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10442000
us-gaap Operating Income Loss
OperatingIncomeLoss
-8882000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54000
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2018Q3 us-gaap Other Operating Income
OtherOperatingIncome
29000
CY2017Q3 us-gaap Other Operating Income
OtherOperatingIncome
35000
us-gaap Other Operating Income
OtherOperatingIncome
100000
us-gaap Other Operating Income
OtherOperatingIncome
58000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
51000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
107000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1799000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
224000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
340000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
977000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
927000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
154000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2262000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1700000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6248000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4028000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82719000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72450000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
84000
CY2017Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
130000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
522000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
379000
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1283000
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1322000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4315000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4708000
us-gaap Share Based Compensation
ShareBasedCompensation
2083000
us-gaap Share Based Compensation
ShareBasedCompensation
1999000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
359958
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1698452
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.72
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4213100
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5549106
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.96
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.80
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.80
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.93
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.41
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2488
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
2944000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
11125000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"><tr style="vertical-align: top;"><td style="width: 27pt;"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">(c)</div></div></div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:27.75pt;margin-right:7.5pt;margin-top:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 63pt; text-align: justify;">The preparation of the financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates. Significant items subject to such estimates and assumptions include share-based compensation, the useful lives of property and equipment, allowances for doubtful accounts and sales returns and inventory valuation.</div></div></div></div></div></div>
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38277908
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38146751
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38254583
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38141654

Files In Submission

Name View Source Status
0001437749-18-019949-index-headers.html Edgar Link pending
0001437749-18-019949-index.html Edgar Link pending
0001437749-18-019949.txt Edgar Link pending
0001437749-18-019949-xbrl.zip Edgar Link pending
bcda-20180930.xml Edgar Link completed
bcda-20180930.xsd Edgar Link pending
bcda-20180930_cal.xml Edgar Link unprocessable
bcda-20180930_def.xml Edgar Link unprocessable
bcda-20180930_lab.xml Edgar Link unprocessable
bcda-20180930_pre.xml Edgar Link unprocessable
bcda20180930_10q.htm Edgar Link pending
ex_127890.htm Edgar Link pending
ex_127891.htm Edgar Link pending
ex_127892.htm Edgar Link pending
ex_127893.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending